title: Six-week outcomes after pegaptanib.
authors.forename: Stefanie
authors.initials: S
authors.lastname: Schuman
authors.forename: Adam H
authors.initials: AH
authors.lastname: Rogers
authors.forename: Jay S
authors.initials: JS
authors.lastname: Duker
authors.forename: Elias
authors.initials: E
authors.lastname: Reichel
authors.forename: Caroline R
authors.initials: CR
authors.lastname: Baumal
mesh_terms: D052157:Aptamers, Nucleotide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008268:Macular Degeneration / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014792:Visual Acuity; D014822:Vitreous Body
chemical_list: D052157:Aptamers, Nucleotide; C495058:pegaptanib